Загрузка...
Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
Despite the therapeutic equivalence between twice-daily and once-daily tacrolimus, patient safety after conversion is still a concern. We reviewed 218 liver transplantation (LT) patients who converted twice-daily to once-daily tacrolimus between May 2011 and January 2014. Thirty (13.8%) patients had...
Сохранить в:
| Опубликовано в: : | J Korean Med Sci |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Academy of Medical Sciences
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056201/ https://ncbi.nlm.nih.gov/pubmed/27709847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.11.1711 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|